Investigating emerging infectious diseases and developing medical countermeasures
Integrated Services Core
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10910185
This study is all about figuring out how infectious diseases start and spread, especially during pandemics, so that researchers can create better vaccines and treatments to help keep you and your loved ones safe from these illnesses.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10910185 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how infectious diseases emerge and spread, particularly in the context of pandemics. The team at the Regional Biocontainment Laboratory collaborates across various disciplines to study the biology of pathogens and their interactions with hosts. By utilizing advanced biosafety level-3 facilities, they aim to accelerate the development of new vaccines and treatments that can be deployed in response to biological threats. Patients may benefit from this research through the eventual availability of effective medical interventions for infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in public health and infectious disease management.
Not a fit: Patients with established chronic infections that are not related to emerging pathogens may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and treatments that protect against emerging infectious diseases.
How similar studies have performed: Previous research in similar biocontainment settings has shown success in developing vaccines and treatments for infectious diseases, indicating a promising potential for this approach.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DUPREX, WILLIAM PAUL — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: DUPREX, WILLIAM PAUL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.